June 3, 2013
Four drug makers including Mochida Pharmaceutical launched on May 31 the biosimilar filgrastim (original product: Gran from Kyowa Hakko Kirin), a recombinant human granulocyte colony stimulating factor (rhG-CSF) preparation. This is the third biosimilar agent launched in Japan. Sales in...read more